Atopic dermatitis differential diagnosis: Difference between revisions
Line 177: | Line 177: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
! Lichen simplex chronicus | ! align="center" style="background:#DCDCDC;" |Lichen simplex chronicus | ||
| | | | ||
| | | | ||
Line 206: | Line 206: | ||
| | | | ||
|- | |- | ||
! Ichthyosis vulgaris | ! align="center" style="background:#DCDCDC;" |Ichthyosis vulgaris | ||
| | | | ||
| | | | ||
Line 235: | Line 235: | ||
| | | | ||
|- | |- | ||
! Nummular Dermatitis | ! align="center" style="background:#DCDCDC;" |Nummular Dermatitis | ||
| | | | ||
| | | | ||
Line 264: | Line 264: | ||
| | | | ||
|- | |- | ||
|Netherton syndrome | ! align="center" style="background:#DCDCDC;" |Netherton syndrome | ||
| | | | ||
| | | | ||
Line 293: | Line 293: | ||
| | | | ||
|- | |- | ||
|Dubowitz syndrome | ! align="center" style="background:#DCDCDC;" |Dubowitz syndrome | ||
| | | | ||
| | | | ||
Line 322: | Line 322: | ||
| | | | ||
|- | |- | ||
|Erythrokeratodermia variabilis | ! align="center" style="background:#DCDCDC;" |Erythrokeratodermia variabilis | ||
| | | | ||
| | | | ||
Line 352: | Line 352: | ||
|- | |- | ||
| rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | | rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes | |||
| | | | ||
| | | | ||
Line 381: | Line 381: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|Candida | ! align="center" style="background:#DCDCDC;" |Candida | ||
| | | | ||
| | | | ||
Line 410: | Line 410: | ||
| | | | ||
|- | |- | ||
|Herpes simplex | ! align="center" style="background:#DCDCDC;" |Herpes simplex | ||
| | | | ||
| | | | ||
Line 439: | Line 439: | ||
| | | | ||
|- | |- | ||
|Staphylococcus aureus | ! align="center" style="background:#DCDCDC;" |Staphylococcus aureus | ||
| | | | ||
| | | | ||
Line 468: | Line 468: | ||
| | | | ||
|- | |- | ||
|Molluscum Contagiosum | ! align="center" style="background:#DCDCDC;" |Molluscum Contagiosum | ||
| | | | ||
| | | | ||
Line 497: | Line 497: | ||
| | | | ||
|- | |- | ||
| | ! align="center" style="background:#DCDCDC;" |Scabies | ||
| | | | ||
| | | | ||
Line 526: | Line 526: | ||
| | | | ||
|- | |- | ||
|HIV | ! align="center" style="background:#DCDCDC;" |HIV | ||
| | | | ||
| | | | ||
Line 556: | Line 556: | ||
|- | |- | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | ||
|Dermatitis herpetiformis | ! align="center" style="background:#DCDCDC;" |Dermatitis herpetiformis | ||
| | | | ||
| | | | ||
Line 585: | Line 585: | ||
| | | | ||
|- | |- | ||
|Pemphigus foliaceus | ! align="center" style="background:#DCDCDC;" |Pemphigus foliaceus | ||
| | | | ||
| | | | ||
Line 614: | Line 614: | ||
| | | | ||
|- | |- | ||
|Graft-versus-host disease | ! align="center" style="background:#DCDCDC;" |Graft-versus-host disease | ||
| | | | ||
| | | | ||
Line 643: | Line 643: | ||
| | | | ||
|- | |- | ||
|Dermatomyositis | ! align="center" style="background:#DCDCDC;" |Dermatomyositis | ||
| | | | ||
| | | | ||
Line 673: | Line 673: | ||
|- | |- | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Wiskott-Aldrich syndrome | ||
| | | | ||
| | | | ||
Line 702: | Line 702: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Hyper-IgE syndrome | |||
| | | | ||
| | | | ||
Line 731: | Line 731: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|DiGeorge syndrome | ! align="center" style="background:#DCDCDC;" |DiGeorge syndrome | ||
| | | | ||
| | | | ||
Line 760: | Line 760: | ||
| | | | ||
|- | |- | ||
|Severe combined immunodeficiency (SCID) | ! align="center" style="background:#DCDCDC;" |Severe combined immunodeficiency (SCID) | ||
| | | | ||
| | | | ||
Line 789: | Line 789: | ||
| | | | ||
|- | |- | ||
|Ataxia telangiectasia | ! align="center" style="background:#DCDCDC;" |Ataxia telangiectasia | ||
| | | | ||
| | | | ||
Line 819: | Line 819: | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic Diseases | ||
|Phenylketonuria | ! align="center" style="background:#DCDCDC;" |Phenylketonuria | ||
| | | | ||
| | | | ||
Line 848: | Line 848: | ||
| | | | ||
|- | |- | ||
|Tyrosinemia | ! align="center" style="background:#DCDCDC;" |Tyrosinemia | ||
| | | | ||
| | | | ||
Line 877: | Line 877: | ||
| | | | ||
|- | |- | ||
|Histidinemia | ! align="center" style="background:#DCDCDC;" |Histidinemia | ||
| | | | ||
| | | | ||
Line 906: | Line 906: | ||
| | | | ||
|- | |- | ||
|Multiple carboxylase deficiency | ! align="center" style="background:#DCDCDC;" |Multiple carboxylase deficiency | ||
| | | | ||
| | | | ||
Line 936: | Line 936: | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional deficiencies | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional deficiencies | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Zinc deficiency | |||
| | | | ||
| | | | ||
Line 965: | Line 965: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|Niacin (B3) deficiency | ! align="center" style="background:#DCDCDC;" |Niacin (B3) deficiency | ||
| | | | ||
| | | | ||
Line 994: | Line 994: | ||
| | | | ||
|- | |- | ||
|Pyridoxine (B6) deficiency | ! align="center" style="background:#DCDCDC;" |Pyridoxine (B6) deficiency | ||
| | | | ||
| | | | ||
Line 1,023: | Line 1,023: | ||
| | | | ||
|- | |- | ||
|Biotin (B7) deficiency | ! align="center" style="background:#DCDCDC;" |Biotin (B7) deficiency | ||
| | | | ||
| | | | ||
Line 1,053: | Line 1,053: | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Mycosis fungoides | |||
| | | | ||
| | | | ||
Line 1,082: | Line 1,082: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|Histiocytosis X | ! align="center" style="background:#DCDCDC;" |Histiocytosis X | ||
| | | | ||
| | | | ||
Line 1,112: | Line 1,112: | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications | ||
|Infliximab | ! align="center" style="background:#DCDCDC;" |Infliximab | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|} | |} | ||
Revision as of 16:25, 11 October 2018
Atopic dermatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Atopic dermatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis |
Risk calculators and risk factors forAtopic dermatitis differential diagnosis |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Atopic dermatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis |
Risk calculators and risk factors for Atopic dermatitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
Differentiating [Disease name] from other Diseases
- Seborrhoeic dermatitis
- onset during the 1st days or weeks of life, absence of pruritus, and presence of greasy scaling on a yellow-red base
- Involvement of the top of the scalp (cradle cap), axilla, and diaper area makes it more likely the patient has seborrheic dermatitis, vs excoriated dermatitis involving the extensor surfaces, face, and trunk favour AE.
- Sarcoptes scabiei
- highly pruritic, erythematous papular lesions. In most cases, the typical burrows can be found on the flexor wrists, finger webs and genitalia. Similar symptoms in other family members
- Seborrhoeic dermatitis
Category | Diseases | Etiology | Inherited | Acquired | Demography | History | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||||||||||||||
Appearance | Itching | Bleeding | Fever | BP | Tenderness | Nail pitting | Other | CBC | ESR/CRP | Electrolytes | BUN/Cr | LFT | ||||||||||||||||
Single/
Multiple |
Rash | Involved areas | Pustule | WBC | Hb | Plt | ||||||||||||||||||||||
Skin disorders | Allergic contact dermatitis | |||||||||||||||||||||||||||
Irritant contact dermatitis | ||||||||||||||||||||||||||||
Seborrheic dermatitis | ||||||||||||||||||||||||||||
Psoriasis | ||||||||||||||||||||||||||||
Lichen simplex chronicus | ||||||||||||||||||||||||||||
Ichthyosis vulgaris | ||||||||||||||||||||||||||||
Nummular Dermatitis | ||||||||||||||||||||||||||||
Netherton syndrome | ||||||||||||||||||||||||||||
Dubowitz syndrome | ||||||||||||||||||||||||||||
Erythrokeratodermia variabilis | ||||||||||||||||||||||||||||
Infection | Dermatophytes | |||||||||||||||||||||||||||
Candida | ||||||||||||||||||||||||||||
Herpes simplex | ||||||||||||||||||||||||||||
Staphylococcus aureus | ||||||||||||||||||||||||||||
Molluscum Contagiosum | ||||||||||||||||||||||||||||
Scabies | ||||||||||||||||||||||||||||
HIV | ||||||||||||||||||||||||||||
Immunologic disorders | Dermatitis herpetiformis | |||||||||||||||||||||||||||
Pemphigus foliaceus | ||||||||||||||||||||||||||||
Graft-versus-host disease | ||||||||||||||||||||||||||||
Dermatomyositis | ||||||||||||||||||||||||||||
Immune deficiency | Wiskott-Aldrich syndrome | |||||||||||||||||||||||||||
Hyper-IgE syndrome | ||||||||||||||||||||||||||||
DiGeorge syndrome | ||||||||||||||||||||||||||||
Severe combined immunodeficiency (SCID) | ||||||||||||||||||||||||||||
Ataxia telangiectasia | ||||||||||||||||||||||||||||
Metabolic Diseases | Phenylketonuria | |||||||||||||||||||||||||||
Tyrosinemia | ||||||||||||||||||||||||||||
Histidinemia | ||||||||||||||||||||||||||||
Multiple carboxylase deficiency | ||||||||||||||||||||||||||||
Nutritional deficiencies | Zinc deficiency | |||||||||||||||||||||||||||
Niacin (B3) deficiency | ||||||||||||||||||||||||||||
Pyridoxine (B6) deficiency | ||||||||||||||||||||||||||||
Biotin (B7) deficiency | ||||||||||||||||||||||||||||
Malignancy | Mycosis fungoides | |||||||||||||||||||||||||||
Histiocytosis X | ||||||||||||||||||||||||||||
Medications | Infliximab |